In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration

Title
In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration
Authors
Keywords
in vivo, CRISPR screening, CRISPRa, liver regeneration, partial hepatectomy, hepatocyte proliferation, inflammatory bowel disease, colitis, chromatin remodeling, bromodomain inhibitors, protein synthesis
Journal
Cell Stem Cell
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-01-31
DOI
10.1016/j.stem.2022.01.001

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started